These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 16997928)

  • 1. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis.
    Hazen GB; Huang M
    Med Decis Making; 2006; 26(5):512-34. PubMed ID: 16997928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian model averaging approach for cost-effectiveness analyses.
    Conigliani C; Tancredi A
    Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of branch length uncertainty on Bayesian posterior probabilities for phylogenetic hypotheses.
    Kolaczkowski B; Thornton JW
    Mol Biol Evol; 2007 Sep; 24(9):2108-18. PubMed ID: 17636043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian estimation of cost-effectiveness: an importance-sampling approach.
    Heitjan DF; Li H
    Health Econ; 2004 Feb; 13(2):191-8. PubMed ID: 14737756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.
    Johnson-Masotti AP; Laud PW; Hoffmann RG; Hayat MJ; Pinkerton SD
    Med Decis Making; 2004; 24(6):634-53. PubMed ID: 15534344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian sample size calculations in phase II clinical trials using informative conjugate priors.
    Mayo MS; Gajewski BJ
    Control Clin Trials; 2004 Apr; 25(2):157-67. PubMed ID: 15020034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches for optimal sequential decision analysis in clinical trials.
    Carlin BP; Kadane JB; Gelfand AE
    Biometrics; 1998 Sep; 54(3):964-75. PubMed ID: 9750245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian predictive two-stage design for phase II clinical trials.
    Sambucini V
    Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian methods in cost-effectiveness studies: objectivity, computation and other relevant aspects.
    Armero C; García-Donato G; López-Quílez A
    Health Econ; 2010 Jun; 19(6):629-43. PubMed ID: 19424994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian sensitivity analysis for unmeasured confounding in observational studies.
    McCandless LC; Gustafson P; Levy A
    Stat Med; 2007 May; 26(11):2331-47. PubMed ID: 16998821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting factors predictive of heterogeneity in multivariate event time data.
    Dunson DB; Chen Z
    Biometrics; 2004 Jun; 60(2):352-8. PubMed ID: 15180660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling.
    Spiegelhalter DJ; Best NG
    Stat Med; 2003 Dec; 22(23):3687-709. PubMed ID: 14652869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring fast computational strategies for probabilistic phylogenetic analysis.
    Rodrigue N; Philippe H; Lartillot N
    Syst Biol; 2007 Oct; 56(5):711-26. PubMed ID: 17849326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust Bayesian sample size determination in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2008 Jun; 27(13):2290-306. PubMed ID: 18205170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal sample size determinations from an industry perspective based on the expected value of information.
    Willan AR
    Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.